Plasticity of melanoma in vivo: Murine lesions resulting from Trp53, but not Cdk4 or Arf deregulation, display neural transdifferentiation

Pigment Cell and Melanoma Research

Volumn 26, Issue 5, 2013, Pages 731-734

  Handoko, Herlina Y ^a   Boyle, Glen M ^a   Ferguson, Blake ^a   Muller, H Konrad ^b   Soyer, H Peter ^c   Walker, Graeme J ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF TASMANIA   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Melanoma; Mice; Transdifferentiation; Trp53

Indexed keywords

ARF PROTEIN; CYCLIN DEPENDENT KINASE 4; MYELIN; TRP 53 PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL LINEAGE; CELL TRANSDIFFERENTIATION; DOWN REGULATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VIVO STUDY; MELANOCYTE; MELANOMA; NERVE CELL DIFFERENTIATION; NERVE CELL PLASTICITY; NEURILEMOMA; SCHWANN CELL; UPREGULATION;

MURINAE; MUS;

MELANOMA; MICE; TRANSDIFFERENTIATION; TRP53;

ANIMALS; CELL CYCLE PROTEINS; CELL TRANSDIFFERENTIATION; CYCLIN-DEPENDENT KINASE 4; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MELANOMA; MICE; NEURONS; PROTEOLYSIS; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 84882928288     PISSN: 17551471     EISSN: 1755148X     Source Type: Journal    
DOI: 10.1111/pcmr.12124     Document Type: Article

References (12)

1. Adameyko, I., Lallemend, F., Aquino, J.B. et al. (2009). Schwann cell precursors from nerve innervation are a cellular origin of melanocytes in skin. Cell 139, 366-379.
2. Banerjee, S.S., and Eyden, B. (2008). Divergent differentiation in malignant melanomas: a review. Histopathology 52, 119-129.
3. Bardeesy, N., Bastian, B.C., Hezel, A., Pinkel, D., DePinho, R.A., and Chin, L. (2001). Dual inactivation of RB and p53 pathways in RAS-induced melanomas. Mol. Cell. Biol. 21, 2144-2153.
4. Cahoy, J.D., Emery, B., Kaushal, A. et al. (2008). A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function. J. Neurosci. 28, 264-278.
5. Ferguson, B., Muller, H.K., Handoko, H.Y., Khosrotehrani, K., Beermann, F., Hacker, E., Soyer, H.P., Bosenberg, M., and Walker, G.J. (2010). Differential roles of the pRb and Arf/p53 pathways in murine naevus and melanoma genesis. Pigment Cell Melanoma Res. 23, 771-780.
6. Hodis, E., Watson, I.R., Kryukov, G.V. et al. (2012). A landscape of driver mutations in melanoma. Cell 150, 251-263.
7. Hoek, K.S., Schlegel, N.C., Eichhoff, O.M. et al. (2008). Novel MITF targets identified using a two-step DNA microarray strategy. Pigment Cell Melanoma Res. 21, 665-676.
8. Huijbers, I.J., Krimpenfort, P., Chomez, P., van der Valk, M.A., Song, J.-Y., Inderberg-Suso, E.-M., Schmitt-Verhulst, A.-M., Berns, A., and Van den Eynde, B.J. (2006). An inducible mouse model of melanoma expressing a defined tumor antigen. Cancer Res. 66, 3278-3286.
9. Sensi, M., Catani, M., Castellano, G. et al. (2011). Human cutaneous melanomas lacking MITF and melanocyte differentiation antigens express a functional Axl receptor kinase. J. Invest. Dermatol. 131, 2448-2457.
10. Tedeschi, A., and Di Giovanni, S. (2009). The non-apoptotic role of p53 in neuronal biology: enlightening the dark side of the moon. EMBO Rep. 10, 576-583.
11. Walker, G.J., Soyer, H.P., Terzian, T., and Box, N.F. (2011). Modelling melanoma in mice. Pigment Cell Melanoma Res 24, 1158-1176.
12. Wurm, E.M.T., Lin, L.L., Ferguson, B., Lambie, D., Prow, T.W., Walker, G.J., and Soyer, H.P. (2012). Histopathologic and clinical variability in melanocytic lesions developing in genetically modified Cdk4R24C/R24C::Tyr-Nras mice. Exp. Dermatol. 21, 676-681.